Aurora Cannabis (ACB) Goodwill & Intangibles (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Goodwill & Intangibles of $42.4 million for Q1 2026, down 31.73% year-on-year from $62.0 million in Q1 2025, and down 3.64% on a QoQ basis from $44.0 million in Q4 2025.
Aurora Cannabis (ACB) Goodwill & Intangibles (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Goodwill & Intangibles for 9 consecutive years, with $42.4 million the latest figure, recorded in Q1 2026.
- Quarterly Goodwill & Intangibles fell 31.73% year-over-year to $42.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.4 million (down 31.73% YoY) and the FY2026 annual result came in at $42.0 million, down 34.37% from the prior year.
- Goodwill & Intangibles retreated to $42.4 million in Q1 2026 per ACB's latest filing, from $44.0 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for ACB reached as high as $389.0 million in Q1 2022 and fell as low as $42.4 million in Q1 2026.
- A 5-year average of $84.6 million and a median of $62.0 million in 2025 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles slumped 94.57% — and 2025, when it surged 113.91%.
- Year by year, Goodwill & Intangibles stood at $73.2 million in 2022, then slipped by 20.6% to $58.1 million in 2023, then increased by 7.03% to $62.2 million in 2024, then retreated by 29.34% to $44.0 million in 2025, then declined by 3.64% to $42.4 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $42.4 million, $44.0 million, and $133.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.36 Mn |
| Dec 31, 2025 | 43.96 Mn |
| Sep 30, 2025 | 133.72 Mn |
| Jun 30, 2025 | 65.52 Mn |
| Mar 31, 2025 | 62.05 Mn |
| Dec 31, 2024 | 62.22 Mn |
| Sep 30, 2024 | 62.51 Mn |
| Jun 30, 2024 | 61.36 Mn |
| Mar 31, 2024 | 62.36 Mn |
| Dec 31, 2023 | 58.13 Mn |
| Sep 30, 2023 | 58.81 Mn |
| Jun 30, 2023 | 58.48 Mn |
| Mar 31, 2023 | 57.99 Mn |
| Dec 31, 2022 | 73.21 Mn |
| Sep 30, 2022 | 90.86 Mn |
| Jun 30, 2022 | 55.45 Mn |
| Mar 31, 2022 | 388.98 Mn |
| Dec 31, 2021 | 986.41 Mn |
| Sep 30, 2021 | 992.43 Mn |
| Jun 30, 2021 | 1.02 Bn |